vs
Maplebear Inc.（CART）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是Maplebear Inc.的1.5倍（$1.5B vs $992.0M），Steris净利率更高（12.9% vs 8.2%，领先4.7%），Maplebear Inc.同比增速更快（12.3% vs 9.2%），Steris自由现金流更多（$199.5M vs $171.0M），过去两年Steris的营收复合增速更高（15.8% vs 10.0%）
Maplebear Inc. 以Instacart为品牌开展业务，是总部位于美国旧金山的零售媒体及配送企业，在美国和加拿大运营生鲜杂货配送与自提服务。用户可通过官网及移动应用从合作商户订购食品杂货，在法律允许的地区还可选购酒类商品，所有订单由专属采购专员负责拣选、打包并配送上门。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
CART vs STE — 直观对比
营收规模更大
STE
是对方的1.5倍
$992.0M
营收增速更快
CART
高出3.2%
9.2%
净利率更高
STE
高出4.7%
8.2%
自由现金流更多
STE
多$28.5M
$171.0M
两年增速更快
STE
近两年复合增速
10.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $992.0M | $1.5B |
| 净利润 | $81.0M | $192.9M |
| 毛利率 | 72.3% | 43.8% |
| 营业利润率 | 9.9% | 18.3% |
| 净利率 | 8.2% | 12.9% |
| 营收同比 | 12.3% | 9.2% |
| 净利润同比 | -45.3% | 11.2% |
| 每股收益（稀释后） | $0.31 | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CARTSTE
| Q4 25 | $992.0M | $1.5B | ||
| Q3 25 | $939.0M | $1.5B | ||
| Q2 25 | $914.0M | $1.4B | ||
| Q1 25 | $897.0M | $1.5B | ||
| Q4 24 | $883.0M | $1.4B | ||
| Q3 24 | $852.0M | $1.3B | ||
| Q2 24 | $823.0M | $1.3B | ||
| Q1 24 | $820.0M | $1.1B |
净利润CARTSTE
| Q4 25 | $81.0M | $192.9M | ||
| Q3 25 | $144.0M | $191.9M | ||
| Q2 25 | $116.0M | $177.4M | ||
| Q1 25 | $106.0M | $145.7M | ||
| Q4 24 | $148.0M | $173.5M | ||
| Q3 24 | $118.0M | $150.0M | ||
| Q2 24 | $61.0M | $145.4M | ||
| Q1 24 | $130.0M | $-1.4M |
毛利率CARTSTE
| Q4 25 | 72.3% | 43.8% | ||
| Q3 25 | 73.7% | 44.2% | ||
| Q2 25 | 74.2% | 45.1% | ||
| Q1 25 | 74.8% | 43.3% | ||
| Q4 24 | 75.2% | 44.5% | ||
| Q3 24 | 75.2% | 43.6% | ||
| Q2 24 | 75.7% | 44.7% | ||
| Q1 24 | 74.9% | 40.2% |
营业利润率CARTSTE
| Q4 25 | 9.9% | 18.3% | ||
| Q3 25 | 17.7% | 18.2% | ||
| Q2 25 | 13.6% | 17.7% | ||
| Q1 25 | 12.3% | 14.6% | ||
| Q4 24 | 17.6% | 17.9% | ||
| Q3 24 | 16.2% | 16.5% | ||
| Q2 24 | 6.3% | 14.5% | ||
| Q1 24 | 17.6% | 22.0% |
净利率CARTSTE
| Q4 25 | 8.2% | 12.9% | ||
| Q3 25 | 15.3% | 13.1% | ||
| Q2 25 | 12.7% | 12.8% | ||
| Q1 25 | 11.8% | 9.8% | ||
| Q4 24 | 16.8% | 12.7% | ||
| Q3 24 | 13.8% | 11.3% | ||
| Q2 24 | 7.4% | 11.4% | ||
| Q1 24 | 15.9% | -0.1% |
每股收益（稀释后）CARTSTE
| Q4 25 | $0.31 | $1.96 | ||
| Q3 25 | $0.51 | $1.94 | ||
| Q2 25 | $0.41 | $1.79 | ||
| Q1 25 | $0.37 | $1.48 | ||
| Q4 24 | $0.53 | $1.75 | ||
| Q3 24 | $0.42 | $1.51 | ||
| Q2 24 | $0.20 | $1.46 | ||
| Q1 24 | $0.43 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $687.0M | $423.7M |
| 总债务越低越好 | — | $1.9B |
| 股东权益账面价值 | $2.5B | $7.2B |
| 总资产 | $3.7B | $10.6B |
| 负债/权益比越低杠杆越低 | — | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资CARTSTE
| Q4 25 | $687.0M | $423.7M | ||
| Q3 25 | $1.7B | $319.2M | ||
| Q2 25 | $1.6B | $279.7M | ||
| Q1 25 | $1.6B | $171.7M | ||
| Q4 24 | $1.4B | $155.2M | ||
| Q3 24 | $1.3B | $172.2M | ||
| Q2 24 | $1.4B | $198.3M | ||
| Q1 24 | $1.5B | $207.0M |
总债务CARTSTE
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $3.1B |
股东权益CARTSTE
| Q4 25 | $2.5B | $7.2B | ||
| Q3 25 | $3.5B | $7.0B | ||
| Q2 25 | $3.3B | $7.0B | ||
| Q1 25 | $3.2B | $6.6B | ||
| Q4 24 | $3.1B | $6.4B | ||
| Q3 24 | $2.9B | $6.6B | ||
| Q2 24 | $3.0B | $6.4B | ||
| Q1 24 | $3.1B | $6.3B |
总资产CARTSTE
| Q4 25 | $3.7B | $10.6B | ||
| Q3 25 | $4.5B | $10.4B | ||
| Q2 25 | $4.4B | $10.4B | ||
| Q1 25 | $4.3B | $10.1B | ||
| Q4 24 | $4.1B | $10.0B | ||
| Q3 24 | $3.9B | $10.2B | ||
| Q2 24 | $4.0B | $10.1B | ||
| Q1 24 | $4.1B | $11.1B |
负债/权益比CARTSTE
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.33× | ||
| Q2 24 | — | 0.35× | ||
| Q1 24 | — | 0.50× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.0M | $298.2M |
| 自由现金流经营现金流 - 资本支出 | $171.0M | $199.5M |
| 自由现金流率自由现金流/营收 | 17.2% | 13.3% |
| 资本支出强度资本支出/营收 | 1.2% | 6.6% |
| 现金转化率经营现金流/净利润 | 2.26× | 1.55× |
| 过去12个月自由现金流最近4个季度 | $910.0M | $917.1M |
8季度趋势，按日历期对齐
经营现金流CARTSTE
| Q4 25 | $183.0M | $298.2M | ||
| Q3 25 | $287.0M | $287.8M | ||
| Q2 25 | $203.0M | $420.0M | ||
| Q1 25 | $298.0M | $260.8M | ||
| Q4 24 | $153.0M | $332.8M | ||
| Q3 24 | $185.0M | $250.7M | ||
| Q2 24 | $244.0M | $303.7M | ||
| Q1 24 | $105.0M | $254.8M |
自由现金流CARTSTE
| Q4 25 | $171.0M | $199.5M | ||
| Q3 25 | $272.0M | $201.3M | ||
| Q2 25 | $187.0M | $326.4M | ||
| Q1 25 | $280.0M | $189.9M | ||
| Q4 24 | $141.0M | $243.6M | ||
| Q3 24 | $171.0M | $148.8M | ||
| Q2 24 | $220.0M | $195.7M | ||
| Q1 24 | $91.0M | $163.3M |
自由现金流率CARTSTE
| Q4 25 | 17.2% | 13.3% | ||
| Q3 25 | 29.0% | 13.8% | ||
| Q2 25 | 20.5% | 23.5% | ||
| Q1 25 | 31.2% | 12.8% | ||
| Q4 24 | 16.0% | 17.8% | ||
| Q3 24 | 20.1% | 11.2% | ||
| Q2 24 | 26.7% | 15.3% | ||
| Q1 24 | 11.1% | 14.6% |
资本支出强度CARTSTE
| Q4 25 | 1.2% | 6.6% | ||
| Q3 25 | 1.6% | 5.9% | ||
| Q2 25 | 1.8% | 6.7% | ||
| Q1 25 | 2.0% | 4.8% | ||
| Q4 24 | 1.4% | 6.5% | ||
| Q3 24 | 1.6% | 7.7% | ||
| Q2 24 | 2.9% | 8.4% | ||
| Q1 24 | 1.7% | 8.2% |
现金转化率CARTSTE
| Q4 25 | 2.26× | 1.55× | ||
| Q3 25 | 1.99× | 1.50× | ||
| Q2 25 | 1.75× | 2.37× | ||
| Q1 25 | 2.81× | 1.79× | ||
| Q4 24 | 1.03× | 1.92× | ||
| Q3 24 | 1.57× | 1.67× | ||
| Q2 24 | 4.00× | 2.09× | ||
| Q1 24 | 0.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CART
| Transaction | $698.0M | 70% |
| Advertising And Other | $294.0M | 30% |
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
